NEW YORK (TheStreet) -- UnitedHealth Group
(UNH - Get Report) shares are up 2.4% to $85.81 on Thursday following the release of its second quarter earnings results.
The nation's largest health insurer posted significant gains in its Medicaid segment, although earnings for the quarter fell 2 cents from the year ago period to $1.42 per diluted share.
Must Read: 20 Most Volatile Post-Earnings Stocks
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
However, the company's earnings for the quarter were well ahead of analysts expectations of $1.26 per share.
UnitedHealth Group also reported revenue of $32.57 billion in the quarter, a 7% increase from the year ago period.
TheStreet Ratings team rates UNITEDHEALTH GROUP INC as a Buy with a ratings score of A. TheStreet Ratings Team has this to say about their recommendation:
"We rate UNITEDHEALTH GROUP INC (UNH) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income." STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.